Loading...
ROCO
4107
Market cap237mUSD
Oct 08, Last price  
109.50TWD
1D
0.00%
1Q
-6.41%
Jan 2017
-7.98%
IPO
297.46%
Name

Bioteque Corp

Chart & performance

D1W1MN
ROCO:4107 chart
P/E
14.07
P/S
3.55
EPS
7.78
Div yield, %
4.57%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
1.86%
Revenues
2.14b
+3.03%
491,852,000560,061,000654,864,000780,014,000821,623,000760,314,000842,308,000957,883,0001,123,668,0001,259,420,0001,406,959,0001,420,219,0001,613,009,0001,858,900,0001,947,661,0001,825,491,0002,010,272,0001,944,701,0002,072,575,0002,135,451,000
Net income
539m
+2.07%
57,268,000309,149,000171,455,000158,516,000172,587,000128,597,000166,308,000215,224,000290,902,000315,766,000358,232,000303,939,000404,997,000464,172,000488,665,000431,257,000493,540,000452,550,000528,260,000539,185,000
CFO
657m
-6.52%
77,470,000159,768,000277,232,000174,323,000185,387,000148,434,000183,438,000270,440,000368,709,000385,428,000380,631,000336,514,000460,413,000623,411,000634,506,000469,246,000644,579,000679,375,000702,617,000656,835,000
Dividend
Jul 28, 20265.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen masks and tubing, anesthesia mask, sprayer and spray mask, endotracheal tube, and tracheostomy tube. It also provides pig tail drainage tube assembly, pig tail drainage tube, percutaneous drainage catheter accessories, insertion of drainage catheter kit, puncture and insertion system, snap lock drainage catheter set, ureteral catheter, propulsion tube, ureteral balloon dilation catheter, subcutaneous pyelostomy with ureteral catheterization, kidney transplantation ureteral catheter, tumor ureteral catheter, ureteroscopy applicable ureteral catheter, angle sleeve, and urinary tract stone removal products. In addition, it offers blood circuit tube parts, deodorizing and antibacterial spray, biliary balloon dilation catheter, nasobiliary drainage catheter, surgical drainage catheter, leg-binding urine bag, and drainage bag, as well as PVC IV infusion bags, PVC pipe bags, accessories for infusion bags, infusion extension tubing, and IV set. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.

Key people

Yu-Jin Lin
Head of Accounting · since 2025
Pei-Zhi Zhong
Corporate Governance Officer · since 2025
Ming-Yeh Cheng
Director · since 2022
Wei-Hsiu Hong
Director · since 2025
Director · since 2024
Yizhong Huang
Chief Financial Officer, Head of Finance, Director · since 2023
Ming-Zhong Li
Chairman of the Board · since 2023
Hong-Ying Li
Director · since 2023
Yi-Xun Li
Senior Deputy General Manager, Director · since 2012
Jin-Long Lin
General Manager, Director · since 2025
Jing-Yi Tsai
Deputy General Manager, Director · since 2025
Xing Wang
Director · since 2022
Yiu-Cho Chin
Independent Director · since 2023
Independent Director · since 2025
Bin-Xi Lin
Independent Director · since 2018
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT